SANGAMO THERAPEUTICS, INC (SGMO) › Total LiabilitiesSANGAMO THERAPEUTICS, INC (SGMO) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2011: $7.20M2012: $17.64M2013: $19.13M2014: $36.58M2015: $24.80M2016: $21.70M2017: $98.84M2018: $223.14M2019: $204.78M2020: $441.18M2021: $346.58M2022: $267.55M2023: $82.43M2024: $78.86M2025: $74.01M$74.01M2011Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$74.01M-6.2%2024$78.86M-4.3%2023$82.43M-69.2%2022$267.55M-22.8%2021$346.58M-21.4%2020$441.18M+115.4%2019$204.78M-8.2%2018$223.14M+125.8%2017$98.84M+355.6%2016$21.70M-12.5%2015$24.80M-32.2%2014$36.58M+91.2%2013$19.13M+8.5%2012$17.64M+144.8%2011$7.20M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share